Conversion Consideration. (i) Generally. Subject to Section 5.03(A)(ii) and Section 5.03(A)(iii), the type and amount of consideration (the “Conversion Consideration”) due in respect of each $1,000 principal amount of a Note to be converted will be a number of shares of Common Stock equal to the Conversion Rate in effect on the Conversion Date for such conversion.
Appears in 4 contracts
Sources: First Supplemental Indenture (Xeris Biopharma Holdings, Inc.), Indenture, First Supplemental Indenture (Xeris Pharmaceuticals Inc)
Conversion Consideration. (i) Generally. Subject to Section Sections 5.03(A)(ii) and Section 5.03(A)(iii), the type and amount of consideration (the “Conversion Consideration”) due in respect of each $1,000 principal amount of a Note to be converted will be (1) a number of shares of Common Stock equal to the Conversion Rate in effect on the Conversion Date for such conversion; and (2) a cash amount equal to the Coupon Make-Whole Premium in respect of such $1,000 principal amount.
Appears in 1 contract